Lord, Abbett & Co. LLC Bio Techne Corp Transaction History

Lord, Abbett & Co. LLC

  • $29.9 Billion
  • Q2 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 333,163 shares of TECH stock, worth $24.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
333,163
Previous 278,468 19.64%
Holding current value
$24.9 Million
Previous $19.6 Million 21.78%
% of portfolio
0.08%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$62.12 - $84.15 $3.4 Million - $4.6 Million
54,695 Added 19.64%
333,163 $23.9 Million
Q1 2024

May 09, 2024
BUY
$65.98 - $77.09 $1.14 Million - $1.33 Million
17,288 Added 6.62%
278,468 $19.6 Million
Q4 2023

Feb 12, 2024
SELL
$52.83 - $78.22 $118,075 - $174,821
-2,235 Reduced 0.85%
261,180 $20.2 Million
Q3 2023

Nov 13, 2023
BUY
$67.52 - $89.42 $88,856 - $117,676
1,316 Added 0.5%
263,415 $17.9 Million
Q2 2023

Aug 14, 2023
SELL
$73.76 - $85.98 $5 Million - $5.83 Million
-67,753 Reduced 20.54%
262,099 $21.4 Million
Q1 2023

May 12, 2023
SELL
$71.62 - $86.62 $186,212 - $225,212
-2,600 Reduced 0.78%
329,852 $24.5 Million
Q4 2022

Feb 10, 2023
BUY
$80.67 - $352.29 $20.6 Million - $89.9 Million
255,192 Added 330.3%
332,452 $27.6 Million
Q3 2022

Nov 14, 2022
BUY
$282.54 - $391.85 $141,552 - $196,316
501 Added 0.65%
77,260 $21.9 Million
Q2 2022

Aug 12, 2022
BUY
$322.67 - $449.65 $46,464 - $64,749
144 Added 0.19%
76,759 $26.6 Million
Q1 2022

May 13, 2022
SELL
$353.85 - $487.79 $6.93 Million - $9.56 Million
-19,597 Reduced 20.37%
76,615 $33.2 Million
Q4 2021

Feb 11, 2022
BUY
$456.15 - $525.06 $738,506 - $850,072
1,619 Added 1.71%
96,212 $49.8 Million
Q3 2021

Nov 09, 2021
SELL
$444.87 - $538.88 $2.1 Million - $2.55 Million
-4,731 Reduced 4.76%
94,593 $45.8 Million
Q2 2021

Aug 11, 2021
BUY
$387.35 - $450.26 $2.51 Million - $2.92 Million
6,483 Added 6.98%
99,324 $44.7 Million
Q1 2021

May 11, 2021
SELL
$314.62 - $411.0 $1.98 Million - $2.59 Million
-6,309 Reduced 6.36%
92,841 $35.5 Million
Q4 2020

Feb 09, 2021
SELL
$246.9 - $321.87 $691,320 - $901,236
-2,800 Reduced 2.75%
99,150 $31.5 Million
Q3 2020

Nov 12, 2020
SELL
$232.22 - $282.96 $882,436 - $1.08 Million
-3,800 Reduced 3.59%
101,950 $25.3 Million
Q2 2020

Aug 14, 2020
BUY
$185.43 - $279.56 $111,814 - $168,574
603 Added 0.57%
105,750 $27.9 Million
Q1 2020

May 14, 2020
SELL
$161.17 - $221.51 $116,525 - $160,151
-723 Reduced 0.68%
105,147 $19.9 Million
Q4 2019

Feb 14, 2020
SELL
$189.68 - $222.09 $5.49 Million - $6.42 Million
-28,918 Reduced 21.45%
105,870 $23.2 Million
Q3 2019

Nov 14, 2019
BUY
$183.56 - $216.72 $22.7 Million - $26.8 Million
123,717 Added 1117.49%
134,788 $26.4 Million
Q2 2019

Aug 14, 2019
BUY
$188.72 - $215.43 $2.09 Million - $2.39 Million
11,071 New
11,071 $2.31 Million
Q4 2018

Feb 14, 2019
SELL
$132.75 - $203.8 $44.6 Million - $68.5 Million
-336,248 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$147.44 - $204.11 $6.73 Million - $9.31 Million
-45,636 Reduced 11.95%
336,248 $68.6 Million
Q2 2018

Aug 14, 2018
BUY
$144.9 - $165.58 $8.77 Million - $10 Million
60,508 Added 18.83%
381,884 $56.5 Million
Q1 2018

May 15, 2018
BUY
$131.46 - $151.04 $256,872 - $295,132
1,954 Added 0.61%
321,376 $48.5 Million
Q4 2017

Feb 14, 2018
SELL
$121.17 - $134.75 $901,625 - $1 Million
-7,441 Reduced 2.28%
319,422 $41.4 Million
Q3 2017

Nov 14, 2017
SELL
$113.59 - $123.78 $46,685 - $50,873
-411 Reduced 0.13%
326,863 $39.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
327,274
327,274 $38.5 Million

Others Institutions Holding TECH

# of Institutions
604
Shares Held
153M
Call Options Held
171K
Put Options Held
56.9K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.93B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email